Synthetic Applications of Formal [3+3] Cycloadditions
Synthetic Applications of Formal [3+3] Cycloadditions
批准号:
7236136
负责人:
RICHARD P HSUNG
金额:
$31.03万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-07-01 至 2009-05-31
关键词:
Acetylcholinesterase InhibitorsAcheAcidsAlkaloidsAminesBindingBiological AssayBiological FactorsCyclizationDementiaDevelopmentFamilyGoalsIn VitroKnowledgeMethodologyMethodsNitrogenOxygenReactionResearch PersonnelSaltsVariantamino groupanalogarisugacinarisugacin Acycloadditionhongoquercin Ahyperforinin vitro Assayphomactin Aprograms
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In the previous proposal, we identified the formal [3 + 3] cycloaddition as a viable approach to arisugacin A, a potent inhibitor of acetylcholinesterase [AChE]. We also recognized the potential of the [3 + 3] reaction as a general methodology for constructing heterocycles including nitrogen heterocycles. We have accomplished those goals.
To demonstrate the usefulness of this formal cycloaddition methodology, pursuing its applications in natural product syntheses has become an important focus. Thus, in this competitive renewal, in addition to furthering the medicinal knowledge of arisugacin A for dementias as originally proposed, we intend to pursue syntheses of natural products containing oxygen heterocycles, and to develop a visible program around alkaloid synthesis particularly using the formal aza-[3 + 3] cycloaddition. While we are pursuing several different endeavors, this renewal focuses on selected topics to best illustrate these efforts, and is organized in the following four aims.
Specific Aim 1 [Aim 3 in the previous proposal] focuses on synthesis of analogs of arisugacin A using the formal oxa-[3 + 3] cycloaddition and in vitro assay of the analogs to explore binding of arisugacin A to AChE.
Specific Aim 2 focuses on applications of formal oxa-[3 + 3] cycloadditions in total syntheses of the natural products hongoquercin A and phomactin A.
Specific Aim 3 focuses on employing the oxa-[3 + 3] along with the carbo-[3 + 3] formal cycloaddition toward the synthesis of the hyperforin family of natural products.
Specific Aim 4 focuses on applications of formal aza-[3 + 3] cycloadditions toward total syntheses of lepadins and cylindricines, and further development of the intramolecular formal aza-[3 + 3] cycloaddition including its asymmetric variants using chiral Lewis acids and amine salts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Applications of Yn- and Allenamide Cycloadditions
-
批准号:7261470
-
项目类别:
-
资助金额:$4.67万
-
财政年份:2005
-
负责人:RICHARD P HSUNG
-
依托单位:
Allenamides and Ynamides in Organic Synthesis.
-
批准号:8133852
-
项目类别:
-
资助金额:$30.23万
-
财政年份:2005
-
负责人:RICHARD P HSUNG
-
依托单位:
Applications of Yn- and Allenamide Cycloadditions
-
批准号:7385887
-
项目类别:
-
资助金额:$22.98万
-
财政年份:2005
-
负责人:RICHARD P HSUNG
-
依托单位:
Applications of Yn- and Allenamide Cycloadditions
-
批准号:6868483
-
项目类别:
-
资助金额:$24.06万
-
财政年份:2005
-
负责人:RICHARD P HSUNG
-
依托单位:
Allenamides and Ynamides in Organic Synthesis.
-
批准号:7985283
-
项目类别:
-
资助金额:$30.53万
-
财政年份:2005
-
负责人:RICHARD P HSUNG
-
依托单位:
Allenamides and Ynamides in Organic Synthesis.
-
批准号:8536311
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2005
-
负责人:RICHARD P HSUNG
-
依托单位:
Applications of Yn- and Allenamide Cycloadditions
-
批准号:7025093
-
项目类别:
-
资助金额:$24.52万
-
财政年份:2005
-
负责人:RICHARD P HSUNG
-
依托单位:
Applications of Yn- and Allenamide Cycloadditions
-
批准号:7188494
-
项目类别:
-
资助金额:$23.67万
-
财政年份:2005
-
负责人:RICHARD P HSUNG
-
依托单位:
Allenamides and Ynamides in Organic Synthesis.
-
批准号:8324684
-
项目类别:
-
资助金额:$30.23万
-
财政年份:2005
-
负责人:RICHARD P HSUNG
-
依托单位:
POTENTIAL THERAPEUTICS FOR ALZHEIMER'S DISEASE
-
批准号:6193804
-
项目类别:
-
资助金额:$29.87万
-
财政年份:2000
-
负责人:RICHARD P HSUNG
-
依托单位:
Synthetic Applications of Formal [3+3] Cycloadditions
-
批准号:7071057
-
项目类别:
-
资助金额:$31.98万
-
财政年份:2000
-
负责人:RICHARD P HSUNG
-
依托单位:
POTENTIAL THERAPEUTICS FOR ALZHEIMER'S DISEASE
-
批准号:6639545
-
项目类别:
-
资助金额:$21.42万
-
财政年份:2000
-
负责人:RICHARD P HSUNG
-
依托单位:
POTENTIAL THERAPEUTICS FOR ALZHEIMER'S DISEASE
-
批准号:6540028
-
项目类别:
-
资助金额:$21.48万
-
财政年份:2000
-
负责人:RICHARD P HSUNG
-
依托单位:
Synthetic Applications of Formal [3+3] Cycloadditions
-
批准号:7432490
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2000
-
负责人:RICHARD P HSUNG
-
依托单位:
Synthetic Applications of Formal [3+3] Cycloadditions
-
批准号:7196837
-
项目类别:
-
资助金额:$4.53万
-
财政年份:2000
-
负责人:RICHARD P HSUNG
-
依托单位:
Synthetic Applications of Formal [3+3] Cycloadditions
-
批准号:6898733
-
项目类别:
-
资助金额:$28.05万
-
财政年份:2000
-
负责人:RICHARD P HSUNG
-
依托单位:
Synthetic Applications of Formal [3+3] Cycloadditions
-
批准号:6821660
-
项目类别:
-
资助金额:$32.87万
-
财政年份:2000
-
负责人:RICHARD P HSUNG
-
依托单位:
POTENTIAL THERAPEUTICS FOR ALZHEIMER'S DISEASE
-
批准号:6394027
-
项目类别:
-
资助金额:$21.44万
-
财政年份:2000
-
负责人:RICHARD P HSUNG
-
依托单位:
ASYMMETRIC TOTAL SYNTHESIS OF TETRACYCLINE
-
批准号:2413424
-
项目类别:
-
资助金额:$1.25万
-
财政年份:1997
-
负责人:RICHARD P HSUNG
-
依托单位:
ASYMMETRIC TOTAL SYNTHESIS OF TETRACYCLINE
-
批准号:2059622
-
项目类别:
-
资助金额:$2.37万
-
财政年份:1996
-
负责人:RICHARD P HSUNG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于无机基质固定碳点光学探针研究有机磷农药暴露AChE响应的活体测量
-
批准号:
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2024
-
负责人:冯锋
-
依托单位:
转录因子BMAL1调控AChE在昼夜节律紊乱致认知损害中的作用及分子机制
-
批准号:2024Y9230
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:姜雨
-
依托单位:
基于AChE/NLRP3 靶点研究垂穗石松中抗AD新型黄酮苷
吐星酸酯类成分的发现及作用机制研究
-
批准号:2024JJ8138
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:谭蕾红
-
依托单位:
基于GSK-3β/AChE双重抑制的抗AD杂交分子的设计、合成及作用机制研究
-
批准号:22367005
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:董永喜
-
依托单位:
基于可逆界面传质调控机制的AChE固定化荧光传感器及有机磷农药高灵敏抗干扰速测
-
批准号:32372427
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:冷远逵
-
依托单位:
利用微流体技术合成富缺陷MOFs材料定向捕获AChE酶构筑高性能传感界面
-
批准号:32302225
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:宋丹丹
-
依托单位:
抗基质干扰导向的AChE仿生荧光探针的设计合成及农药残留速测应用
-
批准号:--
-
项目类别:面上项目
-
资助金额:53万元
-
批准年份:2022
-
负责人:郝振霞
-
依托单位:
基于高分辨活性轮廓分析的中药AChE/GSK3β双靶点抑制剂高内涵筛选研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:翟蔓华芸
-
依托单位:
新型AChE/NLRP3双靶点抑制剂—藤石松中抗AD新颖黄酮苷吐星酸酯类成分的发现及作用机制研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:刘阳
-
依托单位:
基于AchE靶点的苗药三两银抗阿尔兹海默症甾体生物碱类化合物发现与作用机制研究
-
批准号:82260833
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:於祥
-
依托单位: